Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

NCT00288951 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

690

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Travoprost 0.004% with and without BAK

Sponsor

Alcon Research